About Orion Oyj 
Orion Oyj
Pharmaceuticals & Biotechnology
Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Company Coordinates 
Company Details
Orionintie 1A , ESPOO None : 02200
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.04%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Timo Maasilta
Independent Vice Chairman of the Board
Ms. Pia Kalsta
Independent Director
Mr. Ari Lehtoranta
Independent Director
Prof. Hilpi Rautelin
Independent Director
Ms. Eija Ronkainen
Independent Director
Mr. Mikael Silvennoinen
Independent Director
Revenue and Profits:
Net Sales:
417 Million
(Quarterly Results - Jun 2025)
Net Profit:
82 Million
Pharmaceuticals & Biotechnology
EUR 6,650 Million ()
19.00
NA
0.00%
0.15
30.73%
6.53






